PeopleBeatingCancer supports an evidence-based integrative approach to cancer care. For most newly diagnosed patients, FDA-approved therapies form the foundation of treatment, while evidence-based complementary therapies may help reduce side effects and improve survivorship.
Click the orange button to the right to learn more.
“We describe baseline incidence and risk factors for new cancers (treatment-related secondary cancer) in 4161 persons receiving autotransplants for multiple myeloma in the United States from 1990
Continue reading